Government panel recommends SII to conduct Covovax vaccine trials on children

The subject expert committee (SEC) of Central Drugs Standards Control Organisation (CDSCO), however, told the company to conduct the trial first only on 100 children and then submit data to the drug regulator. "The trial will continue depending on the data on first 100 children," one of the sources said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3l5ySB0
via IFTTT